Paratek Pharmaceuticals, Inc. PRTK
Set alert
2.23 +2.23 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 127.83M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -27.50
- Beta
- 1.71
- Short ratio
- 1.47
- Inst. own
- 52.56%
- Dividend
- 0.00
- Ex-div date
- Oct 30, 2014
- Earnings
- Nov 2, 2023
- 50-d avg
- 1.98
- 200-d avg
- 2.19
- 1y target
- 3.10
1Y chart
Events in this range
- Nov 3, 2022Earnings: —; estimate -0.27; surprise —%
- Mar 16, 2023Earnings: —; estimate 0.01; surprise —%
- Mar 20, 2023Rating: HC Wainwright & Co. · — → Buy
- May 9, 2023Earnings: —; estimate -0.38; surprise —%
- Jun 7, 2023Downgrade: Jefferies · Buy → Hold
- Jun 7, 2023Downgrade: HC Wainwright & Co. · Buy → Neutral
- Jul 10, 2023Rating: HC Wainwright & Co. · Neutral → Neutral
- Aug 3, 2023Earnings: —; estimate -0.31; surprise —%
Signals (61)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 21, 2023 | 3 years ago |
| SMA: Bullish | Sep 20, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 13, 2023 | 3 years ago |
| SMA: Bullish | Sep 5, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 5, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 1, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 30, 2023 | 3 years ago |
| SMA: Bullish | Aug 24, 2023 | 3 years ago |
| SMA: Bearish | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Aug 18, 2023 | 3 years ago |
| SMA: Bullish | Jun 30, 2023 | 3 years ago |
| SMA: Bearish | Jun 29, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 29, 2023 | 3 years ago |
| SMA: Bullish | Jun 27, 2023 | 3 years ago |
| SMA: Bearish | Jun 26, 2023 | 3 years ago |
| SMA: Bullish | Jun 23, 2023 | 3 years ago |
| SMA: Bearish | Jun 8, 2023 | 3 years ago |
| SMA: Bullish | Jun 7, 2023 | 3 years ago |
| SMA: Bullish | Jun 6, 2023 | 3 years ago |
Newest 20 of 61.
Analyst view
Consensus: buy
Buy
Price target (mean) 3.10 +39.0% upside
Now 2.23
- Target (low)
- 2.15
- Target (mean)
- 3.10
- Target (high)
- 5.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy7
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 3
- 2 months ago 3
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31 | -0.33 – -0.30 | -0.33 | +6.1% | 33.85M | +14.2% | 3 |
| Next quarter | -0.25 | -0.26 – -0.24 | -0.38 | +34.2% | 38.12M | +26.2% | 3 |
| Current year | -0.94 | -1.11 – -0.65 | -1.17 | +19.7% | 154.80M | -3.4% | 3 |
| Next year | -0.08 | -0.64 – 0.44 | -0.94 | +91.5% | 221.33M | +43.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 10, 2023 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jun 7, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 7, 2023 | Jefferies | Downgrade | Buy | Hold |
| Mar 20, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| May 6, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 17, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 10, 2022 | WBB Securities | Upgrade | Buy | Strong Buy |
| Nov 9, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 21, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 23, 2021 | WBB Securities | Upgrade | Speculative Buy | Buy |
| Mar 2, 2021 | Jefferies | Initiated | — | Buy |
| Nov 9, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 11, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 11, 2020 | SVB Leerink | Maintained | — | Outperform |
| Jan 8, 2020 | WBB Securities | Initiated | — | Speculative Buy |
| Jan 2, 2019 | Canaccord Genuity | Initiated | — | Buy |
| Aug 27, 2018 | Bank of America | Initiated | — | Neutral |
| Mar 2, 2018 | H.C. Wainwright | Maintained | Buy | Buy |
| Mar 2, 2018 | Raymond James | Downgrade | Strong Buy | Outperform |
| Oct 24, 2017 | Guggenheim | Initiated | — | Buy |
| May 19, 2017 | Raymond James | Initiated | — | Strong Buy |
| Apr 4, 2017 | Wedbush | Reiterated | — | Outperform |
| Jun 17, 2016 | Ladenburg Thalmann | Maintained | — | Buy |
| Mar 29, 2016 | Cantor Fitzgerald | Initiated | — | Buy |
| Feb 29, 2016 | H.C. Wainwright | Initiated | — | Buy |
| Jul 22, 2015 | Gabelli & Co. | Initiated | — | Buy |
| May 27, 2015 | BTIG Research | Initiated | — | Buy |
| May 15, 2015 | Leerink Swann | Initiated | — | Outperform |
| May 12, 2015 | Cantor Fitzgerald | Initiated | — | Buy |
| May 11, 2015 | Guggenheim | Initiated | — | Buy |